Editöre Mektup
BibTex RIS Kaynak Göster

Tıbbi genetik uygulamalarında altın standart fenomiks: tüm ekzom analizi yapılan 3 nörogenetik hasta örneği

Yıl 2021, Cilt: 46 Sayı: 2, 869 - 871, 30.06.2021

Öz

Tüm ekzom dizileme analizi genetik etiyolojisinde heterojenite gösteren hastalıkların tanısında etkili bir yöntemdir. Ancak, çok sık görülen ve klinik etkisi bilinmeyen varyantların analizi ileri düzeyde klinik yorumlama ve fenotip-genotip korelasyonu gerektirmektedir. Bu sunumda, klinik fenotiplemenin elde edilen veriler ile birlikte değerlendirilmesinin önemini vurgulamak amacıyla, birden fazla kliniğe neden olan gen mutasyonuna sahip 3 olgu sunulmaktadır.

Kaynakça

  • 1. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. Journal of medical genetics2012 Jun;49(6):353-61.
  • 2. Shakiba M, Keramatipour M. Effect of Whole Exome Sequencing in Diagnosis of Inborn Errors of Metabolism and Neurogenetic Disorders. Iranian journal of child neurology2018 Winter;12(1):7-15.
  • 3. Al-Nbaheen MS. Analysis of Downs syndrome with molecular techniques for future diagnoses. Saudi journal of biological sciences2018 Mar;25(3):558-62.
  • 4. Scriver CR. The Metabolic Basis of Inherited Disease: McGraw-Hill Information Services Company; 1995.
  • 5. Scriver C, Beaudet A, Sly W, Valle D, Childs B, Kinzler K, et al. The Metabolic and Molecular Bases of Inherited Disease, 4 volume set: McGraw-Hill Companies,Incorporated; 2000.
  • 6. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. The New England journal of medicine2012 Nov 15;367(20):1921-9.
  • 7. Tarailo-Graovac M, Shyr C, Ross CJ, Horvath GA, Salvarinova R, Ye XC, et al. Exome Sequencing and the Management of Neurometabolic Disorders. The New England journal of medicine2016 Jun 9;374(23):2246-55.

Phenomix as the gold standard in medical genetics applications: three neurogenetic patient samples with full exome analysis

Yıl 2021, Cilt: 46 Sayı: 2, 869 - 871, 30.06.2021

Öz

Phenomix as the gold standard in medical genetics applications: three neurogenetic patient samples with full exome analysis

Kaynakça

  • 1. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. Journal of medical genetics2012 Jun;49(6):353-61.
  • 2. Shakiba M, Keramatipour M. Effect of Whole Exome Sequencing in Diagnosis of Inborn Errors of Metabolism and Neurogenetic Disorders. Iranian journal of child neurology2018 Winter;12(1):7-15.
  • 3. Al-Nbaheen MS. Analysis of Downs syndrome with molecular techniques for future diagnoses. Saudi journal of biological sciences2018 Mar;25(3):558-62.
  • 4. Scriver CR. The Metabolic Basis of Inherited Disease: McGraw-Hill Information Services Company; 1995.
  • 5. Scriver C, Beaudet A, Sly W, Valle D, Childs B, Kinzler K, et al. The Metabolic and Molecular Bases of Inherited Disease, 4 volume set: McGraw-Hill Companies,Incorporated; 2000.
  • 6. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. The New England journal of medicine2012 Nov 15;367(20):1921-9.
  • 7. Tarailo-Graovac M, Shyr C, Ross CJ, Horvath GA, Salvarinova R, Ye XC, et al. Exome Sequencing and the Management of Neurometabolic Disorders. The New England journal of medicine2016 Jun 9;374(23):2246-55.
Toplam 7 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Klinik Tıp Bilimleri
Bölüm Editöre Mektup
Yazarlar

Sevcan Tuğ Bozdoğan 0000-0003-3853-8212

Ibrahım Boga Bu kişi benim 0000-0002-8967-8218

Atıl Bişgin 0000-0002-2053-9076

Yayımlanma Tarihi 30 Haziran 2021
Kabul Tarihi 16 Nisan 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 46 Sayı: 2

Kaynak Göster

MLA Tuğ Bozdoğan, Sevcan vd. “Tıbbi Genetik uygulamalarında altın Standart Fenomiks: Tüm Ekzom Analizi yapılan 3 nörogenetik Hasta örneği”. Cukurova Medical Journal, c. 46, sy. 2, 2021, ss. 869-71.